Clinical Drug Experience Knowledgebase

Amyloidosis (Phase 3)

Antigens, CD20 (Phase 1)

Antiphospholipid Syndrome (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Autoimmune Diseases (Phase 2)

Autoimmune Diseases of the Nervous System (Phase 2)

beta-Thalassemia (Phase 2)

Bone Marrow Cells (Phase 2)

Brain Neoplasms (Phase 3)

Breast Neoplasms (Phase 2)

Bronchopulmonary Dysplasia (Phase 1)

Burkitt Lymphoma (Phase 2)

Cardiomyopathies (Phase 2)

Cerebellar Diseases (Phase 2)

Cerebral Palsy (Phase 2)

Chromosome Aberrations (Phase 2)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 1)

Coronary Artery Bypass (Phase 1/Phase 2)

Crohn Disease (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diploidy (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Encephalitis (Phase 2)

Endocrine System Diseases (Phase 1/Phase 2)

Glioblastoma (Phase 2/Phase 3)

Glioma (Phase 1)

Gliosarcoma (Phase 1/Phase 2)

Glucose Metabolism Disorders (Phase 1/Phase 2)

Graft vs Host Disease (Phase 2)

Hamartoma (Phase 1)

Hematopoietic Stem Cell Transplantation (Phase 2)

HIV Infections (Phase 1/Phase 2)

Hodgkin Disease (Phase 2)

Immune System Diseases (Phase 1/Phase 2)

Infertility, Male (Phase 2)

Intestinal Neoplasms (Phase 2)

Intraocular Lymphoma (Early Phase 1)

Lambert-Eaton Myasthenic Syndrome (Phase 2)

Leukemia (Phase 3)

Leukemia, Eosinophilic, Acute (Phase 3)

Leukemia, Hairy Cell (Phase 1)

Leukemia, Large Granular Lymphocytic (Early Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 1)

Leukemia, Monocytic, Acute (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2/Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myelomonocytic, Acute (Phase 3)

Leukemia, Plasma Cell (Phase 2)

Leukemia, Prolymphocytic (Phase 1/Phase 2)

Leukemia, Prolymphocytic, B-Cell (Phase 2)

Leukemia, Prolymphocytic, T-Cell (Phase 2)

Lupus Erythematosus, Systemic (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 1)

Lymphoma, Follicular (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 1)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Early Phase 1)

Lymphomatoid Granulomatosis (Phase 1)

Medulloblastoma (Phase 3)

Melanoma (Phase 1)

Meningitis (Phase 1/Phase 2)

Metabolic Diseases (Phase 1/Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Myasthenia Gravis (Phase 2)

Myelodysplastic Syndromes (Phase 3)

Myocardial Infarction (Phase 3)

Neoplasm Metastasis (Phase 2/Phase 3)

Neoplasm, Residual (Phase 2)

Neoplasms (Phase 2)

Neuroblastoma (Phase 3)

Neuroectodermal Tumors (Phase 3)

Neuromyelitis Optica (Phase 2)

Opsoclonus-Myoclonus Syndrome (Phase 2)

Organ Transplantation (Phase 2)

Osteoarthritis, Hip (Phase 1)

Osteoarthritis, Knee (Phase 1)

Ovarian Neoplasms (Phase 2)

Pemphigus (Phase 1)

Peripheral Vascular Diseases (Phase 1)

Plasmablastic Lymphoma (Phase 1/Phase 2)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)

Retinitis Pigmentosa (Phase 1/Phase 2)

Retinoblastoma (Phase 3)

Rhabdoid Tumor (Phase 3)

Sarcoidosis (Phase 1/Phase 2)

Sarcoma (Phase 3)

Scleroderma, Systemic (Phase 2)

Sezary Syndrome (Phase 1)

Spinal Cord Injuries (Phase 1/Phase 2)

Stem Cell Transplantation (Phase 2)

Stiff-Person Syndrome (Phase 2)

Teratoma (Phase 2)

Testicular Neoplasms (Phase 2)

Translocation, Genetic (Phase 2)

Transplantation, Autologous (Phase 2)

Transplantation, Homologous (Phase 2)

Vasculitis, Central Nervous System (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)